Document Detail


Regional variations in racial differences in the treatment of elderly patients hospitalized with acute myocardial infarction.
MedLine Citation:
PMID:  15589484     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Racial differences in the treatment of patients with myocardial infarction are often presented as nationally consistent patterns of care, despite known regional variations in quality of care. We sought to determine whether racial differences in myocardial infarction treatment vary by U.S. census region.
METHODS: We conducted a retrospective analysis of medical record data from 138,938 elderly fee-for-service Medicare beneficiaries hospitalized with myocardial infarction between 1994 and 1996. Patients were evaluated for the use (admission, discharge) of aspirin and beta-blockers, and cardiac procedures (cardiac catheterization, any coronary revascularization) within 60 days of admission.
RESULTS: Nationally, black patients had lower crude rates of aspirin and beta-blocker use, cardiac catheterization, and coronary revascularization than did white patients. Racial differences in treatment, however, varied by region. Black patients in the Northeast had rates of aspirin use that were similar to those of white patients on admission (50.6% vs. 49.8%, P = 0.58) and at discharge (77.5% vs. 74.2%, P = 0.07), whereas racial differences were observed in the South (admission: 43.7% vs. 48.8%, P <0.001; discharge: 69.5% vs. 73.2%, P <0.001), Midwest (admission: 48.4% vs. 52.3%, P = 0.004), and West (admission: 49.2% vs. 56.2%, P <0.001; discharge: 70.7% vs. 76.2%, P = 0.02). Racial differences in beta-blocker use were comparable across regions (admission: P = 0.59, discharge: P = 0.89). There were no differences in cardiac catheterization use among black and white patients in the Northeast (38.9% vs. 40.5%, P = 0.24), as opposed to the Midwest (43.3% vs. 48.9%, P <0.001), South (39.2% vs. 48.5%, P <0.001), and West (38.3% vs. 48.6%, P <0.001). Similarly, racial differences in any coronary revascularization use were smallest in the Northeast (22.1% vs. 26.7%, P <0.001), greater in the Midwest (24.7% vs. 33.5%, P <0.001), and largest in the South (20.7% vs. 32.0%, P <0.001) and West (22.9% vs. 33.7%, P <0.001). Regional variations in racial differences persisted after multivariable adjustment for aspirin on admission (P = 0.09) and any coronary revascularization (P = 0.10).
CONCLUSION: Racial differences in the use of some therapies for myocardial infarction in patients hospitalized between 1994 and 1996 varied by region, suggesting that national evaluations of racial differences in health care use may obscure potentially important regional variations.
Authors:
Saif S Rathore; Frederick A Masoudi; Edward P Havranek; Harlan M Krumholz
Related Documents :
10732904 - Early postoperative changes in regional systolic and diastolic left ventricular functio...
22971714 - Inhibition of tnf-α by cyclophosphamide reduces myocardial injury after ischemia-reper...
9351724 - Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic c...
24722354 - Zfp580, a novel zinc-finger transcription factor, is involved in cardioprotection of in...
17050344 - Effects of ambient particles and carbon monoxide on supraventricular arrhythmias in a r...
23425544 - Long-term outcome of second-generation everolimus-eluting stents and endeavor zotarolim...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of medicine     Volume:  117     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-13     Completed Date:  2005-01-04     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  811-22     Citation Subset:  AIM; IM    
Affiliation:
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
African Continental Ancestry Group
Aged
Aspirin / therapeutic use
Cardiac Catheterization / utilization
European Continental Ancestry Group
Female
Humans
Inpatients
Male
Medical Records
Midwestern United States
Myocardial Infarction / therapy*
Myocardial Revascularization / utilization
Northwestern United States
Quality of Health Care
Retrospective Studies
United States
Grant Support
ID/Acronym/Agency:
AG01011/AG/NIA NIH HHS; GM07205/GM/NIGMS NIH HHS; T32 GM007205-35/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 50-78-2/Aspirin
Comments/Corrections
Comment In:
Am J Med. 2004 Dec 1;117(11):874-5   [PMID:  15589495 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100.
Next Document:  Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adul...